SG11201502641YA - Antibodies to microbiome, stress factors and mast cell markers as diagnostic markers for ibs - Google Patents
Antibodies to microbiome, stress factors and mast cell markers as diagnostic markers for ibsInfo
- Publication number
- SG11201502641YA SG11201502641YA SG11201502641YA SG11201502641YA SG11201502641YA SG 11201502641Y A SG11201502641Y A SG 11201502641YA SG 11201502641Y A SG11201502641Y A SG 11201502641YA SG 11201502641Y A SG11201502641Y A SG 11201502641YA SG 11201502641Y A SG11201502641Y A SG 11201502641YA
- Authority
- SG
- Singapore
- Prior art keywords
- markers
- microbiome
- ibs
- antibodies
- mast cell
- Prior art date
Links
- 210000003630 histaminocyte Anatomy 0.000 title 1
- 244000005700 microbiome Species 0.000 title 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56911—Bacteria
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/06—Gastro-intestinal diseases
- G01N2800/065—Bowel diseases, e.g. Crohn, ulcerative colitis, IBS
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/60—Complex ways of combining multiple protein biomarkers for diagnosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Cell Biology (AREA)
- Pathology (AREA)
- Biotechnology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Microbiology (AREA)
- General Health & Medical Sciences (AREA)
- Tropical Medicine & Parasitology (AREA)
- Virology (AREA)
- Rheumatology (AREA)
- Rehabilitation Therapy (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Peptides Or Proteins (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261710574P | 2012-10-05 | 2012-10-05 | |
| US201361871853P | 2013-08-29 | 2013-08-29 | |
| PCT/IB2013/059045 WO2014053996A2 (en) | 2012-10-05 | 2013-10-01 | Antibodies to microbiome, stress factors and mast cell markers as diagnostic markers for ibs |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11201502641YA true SG11201502641YA (en) | 2015-05-28 |
Family
ID=49447585
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201502641YA SG11201502641YA (en) | 2012-10-05 | 2013-10-01 | Antibodies to microbiome, stress factors and mast cell markers as diagnostic markers for ibs |
| SG10201702773QA SG10201702773QA (en) | 2012-10-05 | 2013-10-01 | Antibodies to microbiome, stress factors and mast cell markers as diagnostic markers for ibs |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG10201702773QA SG10201702773QA (en) | 2012-10-05 | 2013-10-01 | Antibodies to microbiome, stress factors and mast cell markers as diagnostic markers for ibs |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US10184940B2 (en) |
| EP (1) | EP2904395B1 (en) |
| JP (1) | JP6329553B2 (en) |
| CN (1) | CN104884959B (en) |
| AU (1) | AU2013326133B2 (en) |
| CA (1) | CA2886991A1 (en) |
| MX (1) | MX360479B (en) |
| SG (2) | SG11201502641YA (en) |
| WO (1) | WO2014053996A2 (en) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0720250D0 (en) | 2007-10-17 | 2007-11-28 | Univ Edinburgh | Immunogenic compositions containing escherichia coli h7 flagella and methods of use thereof |
| BR112015027591A2 (en) * | 2013-05-17 | 2017-07-25 | Basf Se | processes for the preparation of an acid, chloride and sulfimine compound |
| JP2016520199A (en) | 2013-05-24 | 2016-07-11 | ネステク ソシエテ アノニム | Pathway-specific markers for diagnosing irritable bowel syndrome |
| AU2016349703A1 (en) | 2015-11-06 | 2018-11-01 | Vetica Labs, Inc. | Methods of detecting inflammatory markers and treating inflammatory conditions in companion animals |
| CA3010042A1 (en) * | 2017-06-29 | 2018-12-29 | Tata Consultancy Services Limited | Method and system for monitoring the gut health of an individual |
| KR20200065022A (en) * | 2017-10-03 | 2020-06-08 | 세레스 테라퓨틱스, 인코포레이티드 | Manipulation of tryptamine metabolism |
| JP6533930B1 (en) | 2018-08-23 | 2019-06-26 | 一般社団法人日本農業フロンティア開発機構 | Method of calculating disease evaluation index, apparatus, system, program, and model creation method for calculating disease evaluation index |
| US11884958B2 (en) | 2019-04-30 | 2024-01-30 | Mayo Foundation For Medical Education And Research | Assessing and treating functional gastrointestinal disorders |
| WO2025071560A1 (en) * | 2023-09-28 | 2025-04-03 | Rutgers, The State University Of New Jersey | Methods of diagnosing b cell malignancies, detecting b cell malignancy relapse, and treating thereof |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2003298703A1 (en) * | 2002-11-22 | 2004-06-18 | Emory University | Diagnostic tests and methods for diagnosing inflammatory bowel disease |
| US20060154276A1 (en) * | 2004-05-13 | 2006-07-13 | Prometheus Laboratories Inc. | Methods of diagnosing inflammatory bowel disease |
| US7943328B1 (en) * | 2006-03-03 | 2011-05-17 | Prometheus Laboratories Inc. | Method and system for assisting in diagnosing irritable bowel syndrome |
| US20080085524A1 (en) | 2006-08-15 | 2008-04-10 | Prometheus Laboratories Inc. | Methods for diagnosing irritable bowel syndrome |
| US20100094560A1 (en) * | 2006-08-15 | 2010-04-15 | Prometheus Laboratories Inc. | Methods for diagnosing irritable bowel syndrome |
| CN102480932B (en) * | 2009-09-01 | 2015-01-14 | 阿昂梅迪克斯公司 | Gut flora-derived extracellular vesicles, and method for searching for a disease model, vaccine, and candidate drug and for diagnosis using same |
| PH12012500850A1 (en) * | 2009-10-30 | 2013-01-07 | Prometheus Laboratories Inc | Methods for diagnosing irritable bowel syndrome |
-
2013
- 2013-10-01 EP EP13779635.5A patent/EP2904395B1/en not_active Not-in-force
- 2013-10-01 AU AU2013326133A patent/AU2013326133B2/en not_active Expired - Fee Related
- 2013-10-01 SG SG11201502641YA patent/SG11201502641YA/en unknown
- 2013-10-01 MX MX2015004271A patent/MX360479B/en active IP Right Grant
- 2013-10-01 CN CN201380063446.2A patent/CN104884959B/en not_active Expired - Fee Related
- 2013-10-01 CA CA2886991A patent/CA2886991A1/en not_active Abandoned
- 2013-10-01 JP JP2015535149A patent/JP6329553B2/en not_active Expired - Fee Related
- 2013-10-01 SG SG10201702773QA patent/SG10201702773QA/en unknown
- 2013-10-01 WO PCT/IB2013/059045 patent/WO2014053996A2/en not_active Ceased
-
2015
- 2015-03-30 US US14/673,660 patent/US10184940B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| HK1213050A1 (en) | 2016-06-24 |
| AU2013326133A1 (en) | 2015-04-23 |
| EP2904395B1 (en) | 2018-09-05 |
| US10184940B2 (en) | 2019-01-22 |
| MX360479B (en) | 2018-11-05 |
| WO2014053996A3 (en) | 2014-05-30 |
| WO2014053996A2 (en) | 2014-04-10 |
| CA2886991A1 (en) | 2014-04-10 |
| AU2013326133B2 (en) | 2019-07-04 |
| JP2015533213A (en) | 2015-11-19 |
| CN104884959B (en) | 2017-12-01 |
| EP2904395A2 (en) | 2015-08-12 |
| JP6329553B2 (en) | 2018-05-23 |
| CN104884959A (en) | 2015-09-02 |
| US20150346200A1 (en) | 2015-12-03 |
| SG10201702773QA (en) | 2017-06-29 |
| MX2015004271A (en) | 2015-08-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL288256A (en) | Digital to biological converter | |
| IL235128B (en) | Nucleic acid sample preparation | |
| SG10201702773QA (en) | Antibodies to microbiome, stress factors and mast cell markers as diagnostic markers for ibs | |
| IL258940B (en) | Anti-il-23p19 antibodies | |
| SG11201500313YA (en) | Single cell analysis using sequence tags | |
| IL235042A0 (en) | Anti-fcrn antibodies | |
| IL234848A0 (en) | Protease-regulated antibodies | |
| IL236259A0 (en) | Anti-siglec-15 antibodies | |
| IL237833A0 (en) | Methods for identifying antibodies with reduced immunogenicity | |
| SG10201700670WA (en) | Cell culture | |
| EP2904382A4 (en) | High aspect ratio structure analysis | |
| EP2872652A4 (en) | Devices and methods for nucleic acid preparation and analysis | |
| EP2804876A4 (en) | Novel antibodies | |
| EP2753629A4 (en) | Sample preparation methods | |
| EP2843042A4 (en) | Cell preparation containing myocardium-committed cell | |
| EP2712550A4 (en) | Lancet | |
| GB201212550D0 (en) | B cell assay | |
| GB201211873D0 (en) | Cell culture | |
| GB201219249D0 (en) | Sample collection | |
| EP2658654A4 (en) | Extraction pipette | |
| TWM443851U (en) | Biological test chip | |
| GB201316110D0 (en) | Phenylboronic Acid | |
| GB201213473D0 (en) | Stress concentration reduction construction | |
| GB201416623D0 (en) | Cell migration assay | |
| GB201014003D0 (en) | Test filing |